TA
Tomohiro Aoki
Princess Margaret Cancer Centre, University of Toronto, University of British Columbia
Research areas: Medicine · Pathology and Forensic Medicine · Lymphoma Diagnosis and Treatment · Viral-associated cancers and disorders · Single-cell and spatial transcriptomics
Employment
-
Princess Margaret Cancer Centre Clinician Scientist (Staff Hematologist)2024 - Present
-
University of Toronto Assistant Professor2024 - Present
-
Princess Margaret Cancer Centre Clinical Research Fellow2023 - 2024
-
British Columbia Cancer Research Centre post doctoral fellow2017 - 2022
Education
Education history is unavailable.
Projects & Funding
-
Deciphering the Role of the Stromal Cell Ecosystem in Hodgkin Lymphoma Lymphoma Research Foundation2024 - 2027
-
Treatment failure in Hodgkin lymphoma: Correlates with genetic mutations and tumor microenvironment Lymphoma Research Foundation2022 - 2024
-
The microenvironment architecture and ecosystem of Hodgkin lymphoma at single cell resolution Lymphoma Research Foundation2021 - 2023
-
Dissecting the Tumour Microenvironment Ecosystem to Overcome Treatment Resistance in Lymphoma Canada Foundation for Innovation / Fondation canadienne pour l'innovation
Publications (48)
- End‐of‐treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T‐cell lymphoma: An Australasian‐Canadian collaborative study Save
- Outcomes of patients with primary refractory and early relapsing large B-cell lymphoma are inferior in the CD19 CAR T era Save
- Data from Multidimensional Characterization of Tumor–Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes Save
- Supplementary Figures S1-S30 from Multidimensional Characterization of Tumor–Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes Save
- Supplementary Figures S1-S30 from Multidimensional Characterization of Tumor–Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes Save
- Supplementary Tables 1-16 from Multidimensional Characterization of Tumor–Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes Save
- Supplementary Tables 1-16 from Multidimensional Characterization of Tumor–Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes Save
- Multidimensional Characterization of Tumor–Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes Save
- Targeted therapy in early-stage classical Hodgkin lymphoma Save
- Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third‐Line CAR T Save
- Characterization of cancer‐associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma Save
- Multidimensional characterization of cellular ecosystems in Hodgkin lymphoma Save
- Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma Save
- Scientific techniques in adolescent and young adult classic Hodgkin lymphoma Save
- Single Cell Spatial Analysis and Biomarker Discovery in Hodgkin Lymphoma Save
- The spatially resolved tumor microenvironment predicts treatment outcome in relapsed/refractory Hodgkin lymphoma Save
- Novel insights into Hodgkin lymphoma biology by single-cell analysis Save
- Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma Save
- Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma Save
- Supplementary Data from Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma Save